Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants

Journal of Heart and Lung Transplantation

Volumn 18, Issue 11, 1999, Pages 1088-1095

  Feeley, Brian T ^a   Park, Aric K ^a   Hoyt, E Grant ^a   Robbins, Robert C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; SALAZOSULFAPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; E-SELECTIN; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INJECTIONS, INTRAPERITONEAL; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NF-KAPPA B; RATS; RATS, INBRED ACI; SULFASALAZINE; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032702174     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00078-9     Document Type: Article

References (42)

1. Butcher E.C. Leukocyte-endothelial cell recognition three (or more) steps of specificity and diversity . Cell. 67:1991;1033-1036.
2. Williams F.M. Neutrophils and myocardial reperfusion injury. Pharmacol Ther. 72:1996;1-12.
3. Siebenlist U., Franzoso G., Brown K. Structure, regulation, and function of NF-κB. Annu Rev Cell Biol. 10:1994;405-455.
4. Baeuerle P.A., Baltimore D. NF-kappa B ten years after . Cell. 87:1996;13-20.
5. Baldwin A.S.J. The NF-κB and IκB proteins new discoveries and insights . Ann Rev Immunol. 14:1996;649-683.
6. Read M.A., Whitley M.Z., Williams A.J., Collins T. NF-kappa B and I kappa B alpha an inducible regulatory system in endothelial activation . J Exp Med. 179:1994;503-512.
7. Stancovski I., Baltimore D. NF-kappaB activation the I kappaB kinase revealed? Cell. 91:1997;299-302.
8. Beg A.A., Baldwin A.S. Jr. The IκB proteins multifunctional regulators of Rel/NF-κB transcription factors . Genes Dev. 7:1993;2064-2070.
9. Scott M.L., Fujita T., Liou H.C., Nolan G.P., Baltimore D. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. 7:1993;1266-1276.
10. Tosa Y., Kollias N., Lee W.P., May J.W.J. Reduction of ischemia-reperfusion injury by monoclonal antibody to intercellular adhesion molecule-1. Transplant Proc. 28:1996;1210-1211.
11. Neish A.S., Williams A.J., Palmer H.J., Whitley M.Z., Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med. 176:1992;1583-1593.
12. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules NF-kappa B and cytokine-inducible enhancers . FASEB J. 9:1995;899-909.
13. Whitley M.Z., Thanos D., Read M.A., Maniatis T., Collins T. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol Cell Biol. 14:1994;6464-6475.
14. Ledebur H.C., Parks T.P. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-κB site and p65 homodimers. J Biol Chem. 270:1995;933-943.
15. Voraberger G., Schafer R., Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol. 147:1991;2777-2786.
16. Iademarco M.F., McQuillan J.J., Rosen G.D., Dean D.C. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem. 267:1992;16323-16329.
17. Kacimi R., Karliner J.S., Koudssi F., Long C.S. Expression and regulation of adhesion molecules in cardiac cells by cytokines. Response to acute hypoxia. Circ Res. 82:1998;576-586.
18. Read M.A., Neish A.S., Gerritsen M.E., Collins T. Postinduction transcriptional repression of E-selectin and vascular cell adhesion molecule-1. J Immunol. 157:1996;3472-3479.
19. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;346-355.
20. Poston R.S., Ennen M., Pollard J., Hoyt E.G., Billingham M.E., Robbins R.C. Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts. J Thorac Cardiovasc Surg. 116:1998;386-396.
21. Feeley B.T., Alexopoulis S., Poston R.S., Hoyt E.G., Ennen M., Robbins R.C. Pressure mediated delivery of AS-ICAM-1 ODN and LFA-1 mAb reduces reperfusion injury in cardiac allografts. Ann Thorac Surg. 68:1999;119-124.
22. Stepkowski S.M. Application of antisense oligodeoxynucleotides for organ transplantation. Transplant Proc. 30:1998;2142-2145.
23. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., Lobb R. Direct expression cloning of vascular cellular adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:1989;1203-1211.
24. Abbassi O., Kishimoto T., McIntire L.V., Anderson D.C., Smith C.W. E-selectin supports neutrophil rolling in vitro under conditions of flow. J Clin Invest. 92:1993;2719-2730.
25. Bevilacqua M., Stengelin S., Gimbrone M., Seed B. Endothelial leukocyte adhesion molecule 1 an inducible receptor for neutrophils related to complement regulatory proteins and lectins . Science. 243:1989;1160-1165.
26. Wahl C., Liptay S., Adler G., Schid R.M. Sulfasalazine a potent and specific inhibitor of nuclear factor kappa B . J Clin Invest. 101:1998;1163-1174.
27. Sheldon P.J., Webb C., Grindulis K.A. Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes - clues to its clinical action? Br J Rheumatol. 27:1988;344-349.
28. Fujiwara M., Mitsui K., Yamamoto I. Inhibition of proliferative responses and interleukin 2 production by salazosulfapyridine and its metabolites. Jpn J Pharmacol. 54:1990;121-132.
29. Grisham M.B. Role of reactive oxygen metabolites in inflammatory bowel disease. Curr Opin Gastoenterol. 9:1993;971-980.
30. Aruom O.I., Wasil M., Halliwell B.M., Hoey J., Butler J. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol. 36:1987;3739-3742.
31. Gionchetti P., Guarnieri C., Campieri M., Bellusgi A., Brignola C., Tannone P., Miglioli M., Barbara C. Scavenger effect of sulfasalazine, 5-aminosalicyclic acid, and osalazine on superoxide radical generation. Dig Dis Sci. 36:1991;174-178.
32. Pierce J.W., Read M.A., Ding H., Luscinskas F.W., Collins T. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol. 156:1996;3961-3969.
33. Ono K., Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 57:1969;225-229.
34. Barone F.C., Hillegrass L.M., Price W.J., White R.F., Lee E.V., Feuerstein G.Z., Sarau H.M., Clark R.K., Griswold D.E. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue myeloperoxidase activity assay and histologic verification . J Neurosci Res. 29:1991;336-434.
35. Lee E.H., Kim H.M. Inhibition of anaphylaxis by sulfasalazine in rats. Pharmacology. 5:1998;223-229.
36. Cooper M., Lindholm P., Pieper G., Seibel R., Moore G., Nakanishi A., Dembny K., Komorowski R., Johnson C., Adams M., Roza A. Myocardial nuclear factor-kappaB activity and nitric oxide production in rejecting cardiac allografts. Transplantation. 66:1998;838-844.
37. Land W. Postischemic reperfusion injury and allograft dysfunction is allograft rejection the result of a fateful confusion by the immune system of danger and benefit? Transplant Proc. 31:1999;332-336.
38. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Novick R.J. The registry of the International Society for Heart and Lung Transplantation fourteenth official report - 1997 . J Heart Lung Transplant. 16:1997;691-712.
39. Baan C.C., Holweg C.T.J., Niesters G.M., van Gelder T., Mol W.M., Zondervan P.E., Mochtar B., Balk A.H.M.M., Weimar W. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation. J Heart Lung Transplant. 17:1998;363-373.
40. Zund G., Dzus A.L., Pretre R., Niederhauser U., Vogt P., Turina M. Endothelial cell injury in cardiac surgery salicylate may be protective by reducing expression of endothelial adhesion molecules . Eur J Cardiothorac Surg. 13:1998;293-297.
41. Land W., Schneeberger H., Schleibner S., Illner W.D., Abendroth D., Rutilli G., Arfors K.E., Messmer K.E. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation. 2:1994;211-217.
42. Land W., Zweier J.L. Prevention of reperfusion-induced, free radical-mediated acute endothelial injury by superoxide dismutase as an effective tool to delay/prevent chronic allograft failure a review . Transplant Proc. 6:1997;2567-2568.